EMEA-003202-PIP01-22 - paediatric investigation plan
Botulinum toxin type A
PIPHuman
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Galderma International S.A.S.
E-mail: info@galderma.com
Tel. +41 584558592